Optical News

LOS ANGELES--(BUSINESS WIRE)--The University Eye Center Los Angeles, part of Ketchum Health, the clinical teaching facility of Marshall B. Ketchum University (MBKU), is partnering with Walgreens to offer free flu shots to uninsured and underinsured Los Angeles residents at three clinics this November, giving patients time to build protection before the holidays. The clinics are aimed at the Angelenos most likely to go without a flu shot. About 1 in 12 Los Angeles County residents had no health...

DURHAM, N.C.--(BUSINESS WIRE)--Wolfspeed, Inc. (NYSE: WOLF), a global leader in silicon carbide (SiC) technology, today announced the commercial introduction of its proprietary transparent silicon carbide (TSiC™) technology expanding the potential of silicon carbide to enable next-generation augmented reality (AR), quantum computing and advanced optical applications. Wolfspeed builds on more than 35 years of silicon carbide innovation, including its pioneering work in LED technology and extensi...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of Pascal Aeschlimann as Vice President of Asia Pacific, effective November 2, 2026. Mr. Aeschlimann, who led STAAR’s commercial expansion across Asia and the Middle East from 2002 to 2010, returns after more than a decade building and leading...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the publication of results from a multinational survey examining symptoms, interactions with health care professionals (HCPs) and treatment experiences to better understand consumer perspectives on dry eye. The findings showed that self-reported dry eye symptoms were more common than reported HCP diagnosis and h...

ALPHARETTA, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its third quarter 2026 financial results before the market opens on Thursday, November 12, 2026, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company’s website at https://ir.nationalvision.com. A live audio webcast of the confer...

MISSOULA, Mont.--(BUSINESS WIRE)--As artificial intelligence continues to transform healthcare, OSRX, Inc. is applying the technology to a common patient frustration: waiting on hold. The Montana-based ophthalmic compounding pharmacy has launched Stella, an AI-powered phone assistant that helps patients pay for compounded medication prescriptions in minutes. Available 24/7, Stella provides immediate assistance with routine order-related questions, giving patients a faster way to complete an imp...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2026 financial results. “Our third-quarter performance reflects the strength and breadth of the business, with growth across all three segments and continued expansion in profitability,” said Thomas J. Appio, chairman and interim CEO, Bausch + Lomb. “We have delivered against the commitments ou...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc. (“Octant”), a clinical-stage drug discovery company developing correctors for protein misfolding diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to OCT-980 for the treatment of retinitis pigmentosa (RP). The designation includes rhodopsin-associated autosomal dominant retinitis pigmentosa (RHO-adRP), the indication for which OCT-980 is currently being developed.OCT-980 is an investiga...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that Warren Foust, President and Chief Executive Officer, and Deborah Andrews, Executive Vice President and Chief Financial Officer, will participate in two investor conferences in November: Stifel 2026 Healthcare Conference Date: Tuesday, November 10, 2026 Location: New York, NY Fires...

MINNEAPOLIS--(BUSINESS WIRE)--New research published in Clinical Imaging suggests that superior mesenteric artery occlusion (SMAO), a life-threatening vascular emergency requiring rapid diagnosis and treatment, may be overlooked on CT interpretation more often than previously recognized. The findings highlight a significant opportunity for radiologists and radiology practices to strengthen evaluation of the superior mesenteric artery and potentially improve patient outcomes. Conducted by resear...